Merck & Co. logo

Merck & Co. MRK

$ 99.73 0.72%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

2.53 B

Market Cap[1]

$ 253 B

EBITDA (LTM)

$ 2.86 B

P/E (LTM)

13.46

P/S (LTM)

3.83

EPS (LTM)

7.34

Merck & Co., Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and distribution of innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has grown to become one of the largest pharmaceutical companies in the world, with operations in over 140 countries.

The company's mission is to improve the health and well-being of people and animals around the world. Merck is committed to discovering new treatments and cures for some of the most challenging diseases, including cancer, Alzheimer's disease, and HIV/AIDS. The company has a strong pipeline of products in development, with a focus on immunotherapy and oncology.

Merck is also a leader in the development and distribution of vaccines. The company has played a key role in the fight against infectious diseases such as measles, mumps, rubella, and HPV. Merck's vaccines have saved countless lives around the world and continue to be an important tool in preventing disease outbreaks.

In addition to its pharmaceutical and vaccine business, Merck also has a thriving animal health division. The company develops and manufactures products for livestock, pets, and wildlife. Merck's animal health products are used to prevent and treat diseases in animals, improving their health and welfare.

Merck is committed to operating responsibly and sustainably. The company has set ambitious goals to reduce its environmental impact, improve the health and safety of its employees, and support the communities where it operates. Merck has been recognized for its sustainability efforts, including being named to the Dow Jones Sustainability Index for the past 16 years.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 25.27 -2.43 % $ 1.22 B Nasdaq Global Select Market usaUSA
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
$ 4.75 1.61 % $ 788 M Nasdaq Global Select Market canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
$ 3.26 -3.12 % $ 252 M Nasdaq Global Select Market usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
$ 7.03 0.14 % $ 260 M Nasdaq Global Select Market israelIsrael
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 220.27 4.81 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
$ 0.91 -5.01 % $ 18.7 M Nasdaq Capital Market israelIsrael
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 0.28 -2.28 % $ 609 M NYSE American israelIsrael
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.3 -3.51 % $ 7.94 B Nasdaq Capital Market australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
$ 89.78 -0.57 % $ 96.9 B Nasdaq Global Select Market britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Anika Therapeutics Anika Therapeutics
ANIK
$ 9.57 0.84 % $ 140 M Nasdaq Global Select Market,SPB usaUSA
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Berkeley Lights Berkeley Lights
BLI
- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
$ 12.05 -7.06 % $ 496 M Nasdaq Capital Market usaUSA
Aytu BioScience Aytu BioScience
AYTU
$ 2.34 2.59 % $ 14.7 M Nasdaq Capital Market usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
- -19.68 % $ 18.4 M Nasdaq Capital Market canadaCanada
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 1.29 -3.01 % $ 7.03 M Nasdaq Global Select Market chinaChina
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Baudax Bio Baudax Bio
BXRX
- 0.59 % $ 63 K Nasdaq Capital Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Catalyst Biosciences Catalyst Biosciences
CBIO
$ 14.01 -8.49 % $ 922 M Nasdaq Capital Market usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
- -0.88 % $ 598 M Nasdaq Capital Market usaUSA
Axon Enterprise Axon Enterprise
AXON
$ 566.18 -2.56 % $ 42.9 B Nasdaq Global Select Market,SPB usaUSA
Cerus Corporation Cerus Corporation
CERS
$ 2.16 0.47 % $ 399 M Nasdaq Global Market usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
- -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Biogen Biogen
BIIB
$ 174.42 1.11 % $ 25.4 B Nasdaq Global Select Market,SPB usaUSA
BioVie BioVie
BIVI
$ 1.42 -5.96 % $ 2.1 M Nasdaq Capital Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 27.36 -2.09 % $ 1.76 M Nasdaq Global Select Market usaUSA
Cortexyme Cortexyme
CRTX
- -1.05 % $ 67.1 M Nasdaq Global Select Market,SPB usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
$ 3.63 -3.97 % $ 44.4 M Nasdaq Capital Market usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
- - $ 2.18 B Nasdaq Global Select Market,SPB usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$ 11.54 0.87 % $ 746 M NYSE usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.